News

Albany International Provides Key Insights on Aerospace Growth

Albany International Provides Key Insights on Aerospace Growth

Albany International's Strategic Update on Aerospace Business

Albany International Corp. (NYSE: AIN) has recently revised its expectations for the aerospace sector within its Engineered Composites (AEC) segment. Through this update, the company informs investors about the anticipated revenue and profitability changes for the upcoming fiscal year. These revisions come in light of a comprehensive quarterly assessment of program expenses and profitable forecasts.

Understanding the Financial Adjustments

Following the company’s detailed analysis of large, complex aerospace contracts, Albany updated its labor, material input, and scrap costs anticipations. These adjustments are primarily due to increased costs and the temporary halt in production at a significant customer, a development awaiting the conclusion of union negotiations. As a result, an expected negative Estimate-at-Completion (EAC) adjustment of approximately $24 million is projected for the third quarter of 2024. Additionally, changes in other forecast parameters may lead to a reduction of $8 million in pre-tax earnings for the latter half of the year.

Momentum in Core Segments

Despite these setbacks, Albany International continues to observe strong momentum in its Machine Clothing and Engineered Composites sectors. Company President and CEO Gunnar Kleveland emphasizes that the integration of Heimbach is progressing well, which positions Albany to capitalize on robust demand offered by their unique innovations across both divisions.

Prospects for Aerospace Programs

Kleveland noted that the company's growth in the aerospace programs is leading to increasingly sophisticated projects. Although challenging, these developments are expected to result in high returns in the form of high-teen EBITDA margins, which are significantly above industry averages. The leadership of Chris Stone as President of AEC brings confidence to navigate these challenges successfully.

Updated Financial Outlook for 2024

As part of the ongoing guidance adjustments for the 2024 fiscal year, Albany has updated its financial outlook as follows:

  • Total company revenue projected between $1.22 billion and $1.26 billion;
  • Effective income tax rate estimated at approximately 27%;
  • Planned capital expenditures in the range of $90 million to $95 million;
  • Adjusted diluted earnings per share expected to be between $2.90 and $3.40, with an EPS bias toward the fourth quarter;
  • Total company Adjusted EBITDA forecasted between $230 million to $250 million;
  • Machine Clothing revenue projected at $740 million to $760 million;
  • Machine Clothing Adjusted EBITDA expected between $235 million and $245 million;
  • Albany Engineered Composites revenue estimated between $480 million to $500 million;
  • Albany Engineered Composites Adjusted EBITDA forecasted between $65 million and $75 million.

Anticipating Future Conference Calls

A conference call concerning these updates will be hosted today. Albany International highly encourages stakeholders to participate. Those interested can join via the company's Investor Relations portal. Post-call, a recording will be available for future reference.

Additional Information

The data in this announcement reflects preliminary findings and may be subject to change. Albany International aims to provide a full report in alignment with its financial closure processes.

Frequently Asked Questions

What are Albany International's updated revenue expectations for 2024?

Albany International expects total company revenue to range between $1.22 billion and $1.26 billion for 2024.

How will the changes in EAC affect the financials?

There will be an approximate $24 million negative EAC adjustment affecting the third quarter of 2024 due to changes in labor and material costs.

What is the expected impact on EBITDA margins?

Albany anticipates maintaining high-teen EBITDA margins, significantly above industry averages despite the financial adjustments.

When will the official financial results be released?

Albany International will report its detailed financial performance as part of their quarterly results soon.

What are the company's main sectors of operation?

Albany operates two primary sectors: Machine Clothing and Albany Engineered Composites, focusing on advanced materials for several industries including aerospace.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 14

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 18

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking the Future: Investing in AI and Emerging Stocks

Updated Category News Views 194

Discover the Potential of the AI Market For anyone looking to elevate their investment portfolio, an understanding of the AI industry is paramount. Presently, the AI market boasts a staggering value of $184 billion. Projections suggest that by the decade's end, this figure could leap to an astounding $827 billion, with an impressive annual growth rate hovering around 30%!...

Continue Reading
Experience Tricoci's Nutrire Signature Head Spa Today

Updated Category News Views 215

Tricoci Salon & Spa rolled out its Nutrire Signature Head Spa Experience, a big deal for the beauty sector. Clients were buzzing about this new service that promised to elevate scalp health while pampering their locks. The vibe? Pure luxury meets targeted care. Nutrire Experience: What's the Buzz? This wasn't just another spa gimmick; it was all about specialized...

Continue Reading
Forbright Bank Celebrated as Leader in Eco-Friendly Banking

Updated Category News Views 224

Forbright Bank Recognized for Environmental Excellence Forbright Bank has proudly received the prestigious title of Best Eco-Friendly Bank in America by Bankrate. This accolade, part of Bankrate’s Best Products in Personal Finance Awards, highlights Forbright Bank's unwavering dedication to sustainability and responsible lending practices. Notably, this award is making...

Continue Reading
CWH Advisors Names Rebika Shaw as New COO for Strategic Growth

Updated Category News Views 216

CWH Advisors Announces New Chief Operating Officer CWH Advisors, a premier consultancy in healthcare management, has appointed Rebika Shaw as its Chief Operating Officer. This strategic advancement aims to enhance operations and drive success within the industry. Rebika Shaw's Role and Responsibilities In her position as COO, Shaw will be responsible for overseeing the...

Continue Reading
Powerfleet Expands Leadership with Jeff Lautenbach as CRO

Updated Category News Views 223

Powerfleet Welcomes Jeff Lautenbach as Chief Revenue Officer Powerfleet, Inc. (Nasdaq: AIOT), a prominent player in the artificial intelligence of things (AIoT) SaaS mobile asset industry, has appointed Jeff Lautenbach as its new Chief Revenue Officer (CRO). This significant move is aimed at amplifying the company's efforts to scale its revenue operations, enhancing its...

Continue Reading